Trial Outcomes & Findings for Prevention of Parastomal Hernia by Mesh Placement (NCT NCT02404545)
NCT ID: NCT02404545
Last Updated: 2017-09-25
Results Overview
Rate of reduction of the incidence of parastomal hernia in study participants, as assessed by physical examination
TERMINATED
NA
12 participants
18 months
2017-09-25
Participant Flow
Participant milestones
| Measure |
Group 1 - Ideal Conduit No Mesh
No mesh will be placed at the time of radical cystectomy and ileal conduit.
|
Group 2 - Ileal Conduit With Mesh
Ethicon Physiomesh will be placed at the time of radical cystectomy and ileal conduit.
Ethicon Physiomesh: Ethicon Physiomesh will be paced at the time of radical cystectomy and ileal conduit.
|
|---|---|---|
|
Overall Study
STARTED
|
6
|
6
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
6
|
6
|
Reasons for withdrawal
| Measure |
Group 1 - Ideal Conduit No Mesh
No mesh will be placed at the time of radical cystectomy and ileal conduit.
|
Group 2 - Ileal Conduit With Mesh
Ethicon Physiomesh will be placed at the time of radical cystectomy and ileal conduit.
Ethicon Physiomesh: Ethicon Physiomesh will be paced at the time of radical cystectomy and ileal conduit.
|
|---|---|---|
|
Overall Study
Sponsor Termination
|
6
|
6
|
Baseline Characteristics
Prevention of Parastomal Hernia by Mesh Placement
Baseline characteristics by cohort
| Measure |
Group 1 - Ideal Conduit No Mesh
n=6 Participants
No mesh will be placed at the time of radical cystectomy and ileal conduit.
|
Group 2 - Ileal Conduit With Mesh
n=6 Participants
Ethicon Physiomesh will be placed at the time of radical cystectomy and ileal conduit.
Ethicon Physiomesh: Ethicon Physiomesh will be paced at the time of radical cystectomy and ileal conduit.
|
Total
n=12 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
5 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
4 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
5 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
6 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 18 monthsPopulation: The study required a minimum of 13 participants enrolled per arm for analysis of this outcome measure. Due to the manufacturer's (Ethicon) termination of the Physiomesh device, the study was prematurely terminated with fewer than minimum number of participants required on each arm, and the data were not analyzed.
Rate of reduction of the incidence of parastomal hernia in study participants, as assessed by physical examination
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 60 monthsPopulation: The study required a minimum of 13 participants enrolled per arm for analysis of this outcome measure. Due to the manufacturer's (Ethicon) termination of the Physiomesh device, the study was prematurely terminated with fewer than minimum number of participants required on each arm, and the data were not analyzed.
Assessed by physical examination including: * Mesh erosion and infection * Stomal stenosis and necrosis * Frequency of stoma pouch appliance changes. * Record by physical exam the incidence of parastomal hernia at 5 years.
Outcome measures
Outcome data not reported
Adverse Events
Group 1 - Ideal Conduit No Mesh
Group 2 - Ileal Conduit With Mesh
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Murugesan Manoharan MD, FRCS (Eng), FRACS (Urol)
Baptist Health South Florida - Miami Cancer Institute
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place